Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

201982 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov, https://clinicaltrials.gov, NCT00424476 (BLISS-52), NCT00410384 (BLISS-76), NCT00732940 (BEL112232), NCT00712933 (BEL112234).

Good health and well-being

Published in: Lara D. Veeken

Volume 59, Issue 2, pp. 281-291

Field-Weighted Citation Impact: 8.85